Andrew Joseph covers health, medicine, and the biopharma industry in Europe. You can reach Andrew on Signal at drewqjoseph.45. LONDON — In the year-plus since Najat Khan joined the AI-focused drug ...

About five years ago, I ran into a problem many people face as they get older: The people I holiday shop for typically just buy everything they want throughout the year. That, of course, left me ...

Management believes it can drastically cut down the time and cost to bring drugs to market. The company is involved with multiple clinical trials, but none of them are in late stages just yet. Its ...

Recursion Pharmaceuticals Inc. (NASDAQ:RXRX) stock is surging on Wednesday, without any news to justify the movement. Session volume stands at 69.3 million versus the average volume of 26.9 million, ...

We independently select these products—if you buy from one of our links, we may earn a commission. All prices were accurate at the time of publishing. I’ve never been good at making a grocery list and ...

When you look back on your life, do you often experience regret, thinking of things you never did or goals you never accomplished? Many people experience a sense of shame and even anxiety that they ...

The world seems to run on to-do lists. You have one for work, another for chores, and a few for long-term goals that are scratched in a planner or scribbled on a sticky note. Writing everything down ...

In an age of constant communication, receiving phone calls or messages from unknown numbers has become increasingly common. Whether it's a missed call from an unfamiliar number, a potential scam or a ...

While inflation is down from a year ago, it has recently started to creep back upward again. When you throw in high interest rates and declining wage growth, many Americans are feeling the financial ...

Forbes contributors publish independent expert analyses and insights. Mark Travers writes about the world of psychology. When you look back on your life, do you often experience regret, thinking of ...

June 10 (Reuters) - Recursion Pharmaceuticals (RXRX.O), opens new tab said on Tuesday it would lay off about 20% of its workforce as the biotech company tries to cope with an industry-wide funding ...